CM
TVTX icon

Caption Management’s Travere Therapeutics TVTX Stock Holding History

Caption Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.2M Buy
681,000
+14,600
+2% +$436K 0.12% 184
2025
Q4 		$25.5M Buy
666,400
+91,000
+16% +$2.96M 0.17% 128
2025
Q3 		$13.8M Buy
575,400
+328,000
+133% +$6.17M 0.11% 200
2025
Q2 		$3.66M Buy
247,400
+88,400
+56% +$1.47M 0.04% 501
2025
Q1 		$2.85M Buy
159,000
+25,000
+19% +$507K 0.03% 575
2024
Q4 		$2.33M Buy
134,000
+50,000
+60% +$884K 0.02% 636
2024
Q3 		$1.18M Buy
+84,000
New +$875K 0.02% 730
2024
Q1 		– Sell
-32,000
Closed -$288K – 1677
2023
Q4 		$288K Sell
32,000
-385,000
-92% -$2.8M ﹤0.01% 1069
2023
Q3 		$3.73M Buy
+417,000
New +$5.88M 0.06% 400
2022
Q4 		– Sell
-125,000
Closed -$3.08M – 1722
2022
Q3 		$3.08M Buy
+125,000
New +$3.23M 0.04% 498
2022
Q1 		– Sell
-25,000
Closed -$775K – 1956
2021
Q4 		$775K Sell
25,000
-125,000
-83% -$3.52M 0.01% 1136
2021
Q3 		$3.64M Buy
150,000
+21,600
+17% +$397K 0.04% 562
2021
Q2 		$1.87M Buy
+128,400
New +$2.53M 0.02% 697
2019
Q4 		– Sell
-100,000
Closed -$1.16M – 1009
2019
Q3 		$1.16M Buy
100,000
+95,000
+1,900% +$1.57M 0.06% 347
2019
Q2 		$100K Buy
+5,000
New +$98.7K 0.01% 610

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Caption Management's TVTX Position: Q1 2026 in Review

Caption Management opened a new position in Travere Therapeutics (TVTX) in Q1 2026: 25,000 shares worth $743K. The stake represents ﹤0.01% of the portfolio and ranks #1104 among its holdings. This is a return to the name: Caption Management previously reported a position in TVTX as recently as Q3 2025.

Caption Management first reported a position in TVTX in Q3 2022 and has held it in 5 quarters since. The position peaked at $1.44M in Q3 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Caption Management held 25,000 shares of Travere Therapeutics worth $743K as of Q1 2026.
  • Travere Therapeutics was a new Caption Management position in Q1 2026.
  • Travere Therapeutics made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1104 holding.
  • Caption Management first reported a position in Travere Therapeutics in Q3 2022 and has held it in 5 quarters since.
  • Caption Management's Travere Therapeutics position peaked at $1.44M in Q3 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.